Medicine Blister Market Outlook 2024 to 2034

The global medicine blisters market size is projected to surpass a valuation of USD 21,083.8 million by 2034. Our consumer product analysts opine that medicine blister manufacturers can expect a CAGR of 5.40% through 2034, with a current valuation of USD 12,460.7 million in 2024.

Attribute Details
Medicine Blister Market Size, 2023 USD 11,822.3 million
Medicine Blister Market Size, 2024 USD 12,460.7 million
Medicine Blister Market Size, 2034 USD 21,083.8 million
Value CAGR (2024 to 2034) 5.40%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Market Highlights

Booming E-commerce Sectors Presents Exceptional Prospects in Blister Packaging

The thriving e-commerce sector provides unparalleled opportunities for enterprises to create blister packaging that meets the needs of online retailers. Packaging options that promote compact size, durability during shipment, and ease of opening appeal to the rising trend of online pharmaceutical sales.

This strategic approach expands market reach and adaptability to changing customer purchasing trends. Companies can gain a competitive advantage in the online marketplace by investing in e-commerce-friendly packaging.

Unit Dose Blister Packaging Meets the Growing Demand for Personalized Packaging

The unit dosage blister packaging trend meets the rising demand for tailored medical solutions. Pharmaceutical businesses can acquire a competitive advantage by catering to patients with complicated regimens. This method streamlines patient compliance and increases convenience, establishing the company as a patient-centric service.

Unit dosage blister packaging can contribute to cost savings by lowering the chance of medication mistakes, hospital admissions, and total healthcare expenses. Furthermore, it is consistent with evolving value-based care models, in which healthcare providers are increasingly focused on results and patient satisfaction, opening doors to long-term cooperation.

Designing Multi-dose Packaging Solutions Presents a Strategic Opportunity

Designing blister packaging for multi-dose regimens offers an advantageous opportunity, particularly in managing chronic diseases. Packaging that arranges and separates dosages for specified times improves patient convenience.

Companies that help efficient multi-dose solutions to enhance drug adherence and overall patient satisfaction. This approach targets the increasing frequency of chronic illnesses, satisfying the unique demands of patients and healthcare professionals, and could increase market share.

Historical Performance of the Medicine Blister Market (2019 to 2023) Vs. Forecast Outlook (2024 to 2034)

Attributes Details
Medicine Blister Market Size (2019) USD 10,294.6 million
Medicine Blister Market Size (2023) USD 11,822.3 million
Medicine Blister Market CAGR (2019 to 2023) 3.50%

The medicine blister market grew by 3.50% from 2019 to 2023. The pharmaceutical industry has witnessed a substantial rise in production levels due to demographic shifts, increased chronic disease prevalence, and improved healthcare access. This growth in pharmaceutical production has naturally increased demand for innovative packaging solutions, with medicine blister packaging emerging as a prominent participant in addressing this increased need.

With a rising emphasis on patient compliance and accurate dosage in healthcare, pharmaceutical corporations have positioned medicine blister packaging as a tactical choice. Its fundamental design promotes precision dosing, enhancing medicine adherence, and decreasing the possibility of dosage mistakes, all of which correspond with the wider aims of healthcare practitioners and regulatory agencies.

In light of increasing environmental consciousness, the pharmaceutical business has undergone a distinct change toward sustainable packaging strategies. Blister packaging has positioned itself well within this sustainability trend, addressing the expectations of environmentally aware stakeholders when produced with eco-friendly materials.

Furthermore, technological improvements have significantly impacted the medication blistering market. Smart packaging that incorporates RFID or NFC technology has gained popularity. These cutting-edge capabilities, which enable real-time tracking and improved supply chain visibility, have become critical elements in the medicine blister market's development.

Technological improvements can improve supply chain visibility, patient interaction, and overall package functionality even further. Blister packaging integration with digital health solutions like medication management applications and telemedicine platforms might become increasingly common. This connection can improve patient adherence, permit remote monitoring, and give valuable data insights for patients and healthcare practitioners.

Ismail Sutaria
Ismail Sutaria

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Medicine Blister Market Trends Analysis

Trends
  • Pharmaceutical businesses actively align with eco-friendly trends by investing in blister packaging solutions that use sustainable materials to fulfill customer needs for ecologically responsible practices.
  • Digital serialization in blister packaging is increasing, offering pharmaceutical businesses a technologically resilient solution to improve traceability, assure regulatory compliance, and combat counterfeiting in the global supply chain.
  • Smart packaging technologies such as RFID and NFC are gaining popularity, allowing pharmaceutical companies to improve operational efficiency, optimize supply chain operations, and leverage real-time data insights for informed decision-making.
  • Temperature monitoring sensors are increasingly being integrated into blister packaging to meet the pharmaceutical supply chain's strict requirements for ensuring the integrity and safety of temperature-sensitive pharmaceuticals.
  • Pharmaceutical firms are introducing gamification into blister packaging to improve patient participation and adherence, transforming daily rituals into entertaining experiences with interactive features, challenges, and prizes.
Opportunities
  • Collaboration with 3D printing technology has the potential to transform blister packaging.
  • As the nutraceutical sector grows, blister packaging will have more opportunities to meet the market's specific demands.
  • The use of blockchain technology in blister packaging allows for improved traceability and transparency across the pharmaceutical supply chain.
  • The development of unique, child-friendly features in blister packaging represents an opportunity.
  • Smart packaging technology improvements will continue to provide chances to improve the functioning of blister packaging.
Challenges
  • The pharmaceutical packaging market is changing, and alternative options are challenging blister packaging. This covers advancements in flexible packaging, environmentally friendly materials, and upcoming technology.
  • Rapid and rigorous changes in regulatory requirements for pharmaceutical packaging serve as an immediate risk, requiring manufacturers to adapt continuously to achieve compliance.
  • Intellectual property concerns, such as patent infringement or the advent of generic alternatives, might constitute a danger.
  • An abrupt shift in customer preferences toward alternate dosage forms or packaging solutions, such as oral films or dissolvable strips, can represent a risk.

Category-wise Insights

High Cost-effectivity Aspects Surge Demand for Thermoforming Technology

Segment Thermoforming (Technology Type)
Value Share (2024) 89.80%

Thermoforming is gaining popularity given its cost-effective scalability, which allows pharmaceutical manufacturers to attain operational advantages at scale while keeping manufacturing costs low. The adaptability of thermoforming technology in dealing with a wide range of materials, including PVC and PET, coincides with the changing requirements of the pharmaceutical blister packaging industry.

This versatility allows for customization and meets unique material needs for various drugs. The flexible manufacturing cycle of thermoforming is a competitive advantage, allowing pharmaceutical businesses to adapt quickly to market dynamics, regulatory turmoil, and changing customer tastes with shorter lead periods.

Increase in Demand for Recyclable and Fire Resistant Thinner Aluminum Foils

Segment Aluminum Foil (Material)
Value Share (2024) 66.30%

The demand for aluminum blister foils in the pharmaceutical industry is driven by its role in adding a solid barrier to moisture and UV rays. When aluminum foil is applied with a suitable sealing agent, the double-coating heat protects the tablet from the influence of the environment.

Because of its small shape and suitability with automated production, aluminum blister foils are crucial in pharmaceutical packaging. For instance, ALFiPa, a manufacturer of aluminum and blister foil for the pharmaceutical and food industry, offers sustainable packaging solutions, which include duplex and triplex lamination using metalized PET film and aluminum.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Countries Value CAGR (2024 to 2034)
United States 4.00%
United Kingdom 3.30%
Germany 5.70%
India 6.90%
China 6.10%

Evolving Retail Pharmacy Dynamics Influence Market Growth in the United States

The blister packaging market size in the United States is likely to develop at a 4.00% CAGR through 2034. Changes in retail pharmacy dynamics, such as the growth of specialty pharmacies and the proliferation of retail clinics, increase the demand for distinctive and personalized pharmaceutical packaging. Blister packaging suits the changing retail environment with its customization options and suitability for specific drugs.

Furthermore, the rise in specialty medications, which frequently necessitate one-of-a-kind packaging solutions, contributes to the development of the pharmaceutical blister packaging industry. Blister packaging's versatility and customization capabilities satisfy the unique requirements of specialty drugs, addressing a growing part of the pharmaceutical industry.

Expansion of Biopharmaceuticals Contributes to Market Expansion in the United Kingdom

The drug blistering packs market in the United Kingdom is expected to expand at a 3.30% CAGR through 2034. The growing importance of biopharmaceuticals in the United Kingdom's pharmaceutical industry creates new packaging issues. With its versatility in various medicine forms, blister packaging assists in meeting the special needs of biopharmaceutical goods, leading to its increased use.

Furthermore, the rising relevance of home healthcare services in the United Kingdom increases the demand for patient-centric packaging. The convenience of blister packaging for home use, combined with its function in improving drug adherence, sets it as a favored alternative for pharmaceuticals provided outside of typical healthcare facilities.

Germany’s Robust Healthcare Digitization Efforts Drive Demand for Medicine Blisters

Germany's medicine blisters industry demand is likely to surge at a 5.70% CAGR through 2034. Germany's ambitious healthcare digitalization efforts and broad acceptance of electronic prescriptions are propelling the blister packaging industry forward. Blister packaging works with ePrescription systems, allowing smooth integration into the digital healthcare environment.

The increased emphasis on Medication Therapy Management (MTM) in the German healthcare sector further leads to the growth of the medicine blisters market. Its capacity to help in systematic medication management coincides with the MTM program's aims of improving patient outcomes and reducing adverse effects.

Government Initiatives for Affordable Healthcare Boost Product Demand in India

The market for medication blister packs in India is expected to thrive at a 6.90% CAGR through 2034. India's emphasis on accessible healthcare, demonstrated by programs like Ayushman Bharat, is driving the market for blister packaging. Blister packaging is an affordable and effective way to dispense medications, fitting well with the budget-conscious healthcare environment.

One aspect affecting blister packaging is the growing use of over-the-counter (OTC) drugs in India. The product's easy-to-use design, lucid dosage instructions, and potential for self-administration conform to the tastes of OTC product buyers.

Emergence of Health Tech and Smart Packaging Solutions Drive Expansion in China

The pharmaceutical blister packaging industry in China is likely to flourish at a 6.10% CAGR through 2034. Blister packaging is becoming increasingly prevalent in China due to the rise of health technology and smart packaging options. Blister packaging incorporating RFID or QR codes aligns more with today's tech-savvy customer base, improving medicine tracking and encouraging wise medical decisions.

Partnerships between pharmaceutical corporations and Chinese technology giants like Tencent and Alibaba influence blister packaging industry dynamics. Blister packaging's integration with digital health ecosystems supports patient involvement and healthcare technology developments, which are in sync with these partnerships.

Competitive Landscape

The medicine blister market is highly competitive, with top manufacturers vying for market share and fierce competition. Prominent pharmaceutical packaging industry players, including Amcor Limited, Bemis Company Inc., and Constantia Flexibles Group, are vying for market share. These industrial titans establish themselves as strong competitors by utilizing their vast distribution networks, advanced manufacturing skills, and economies of scale.

Recent Developments

  • In October 2023, Solvay, a worldwide specialty materials provider, announced Diofan Ultra736, a new polyvinylidene chloride (PVDC) coating solution with an ultra-high water vapor barrier that will reduce the carbon footprint of pharmaceutical blister films. Diofan Ultra736 satisfies regulatory standards for direct pharmaceutical contact as an aqueous dispersion and aids in the production of sustainable films with thinner coating patterns.
  • In February 2023, Maruho Hatsujyo Innovations (MHI), the United States division of Maruho Co. Ltd, a Japanese healthcare corporation with branches in Europe and the United States, launched a blister packing machine designed exclusively for stability testing and other small-run applications. The Eagle-LP-abbreviated for ‘Lab Pack’ - is intended to be a dependable, cost-effective option for research, stability testing, and early small-batch manufacturing.
  • In July 2022, SEA Vision and Marchesini Group introduced a brand-new solution for primary pack serialization and aggregation to the market, which includes a comprehensive set of technologies for printing, inspecting, and packing serialized blisters, as well as performing aggregation with cartons, all integrated in a 4.0 environment.

Key Players in the Medicine Blister Market

  • Amcor Limited
  • Bemis Company Inc.
  • Constantia Flexibles Group
  • Sonoco Products Company
  • WestRock Company
  • Uflex Ltd.
  • Klöckner Pentaplast Group
  • Bilcare Limited
  • Honeywell International Inc.
  • Winpak Ltd.
  • Tekni-Plex Inc.
  • Essentra plc
  • Berry Global Group, Inc.
  • Huhtamäki Oyj
  • Svam Packaging Industries Pvt. Ltd.

Medicine Blister Market Segmentation

By Product Type:

  • Clamshell
  • Carded

By Technology:

  • Cold Forming
  • Thermoforming

By Material:

  • Plastic
    • PVC/Vinyl
    • PET
    • PE
    • Others
  • Aluminum
  • Paper & Paperboard
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific (APAC)
  • The Middle East & Africa (MEA)
  • Japan

Frequently Asked Questions

How Big is the Medicine Blister Market?

The medicine blister market size is valued at USD 12,460.7 million in 2024.

What is the Projected CAGR of the Medicine Blister Market?

The medicine blister market size is expected to rise at a 5.40% CAGR through 2034.

How Big Will the Medicine Blister Market by 2034?

The medicine blister market is likely to be worth USD 21,083.8 million by 2034.

Which is the Leading Technology Type in the Medicine Blister Market?

Thermoforming technology is highly preferred in the medicine blister market.

Which Country is Rising at a Higher CAGR in the Medicine Blister Market?

India's medicine blister market size is expected to rise at a 6.90% CAGR through 2034.

Table of Content
	1. Executive Summary
	2. Market Overview
	3. Market Background
	4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
	5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
		5.1. Clamshell
		5.2. Carded
	6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology Type
		6.1. Cold Forming
		6.2. Thermoforming
	7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Material Type
		7.1. Polyethylene Terephthalate (PET, PETE, PETG or polyester)
		7.2. High Density Polyethylene (HDPE)
		7.3. Polyvinyl Chloride (PVC)
		7.4. Low Density Polyethylene (LDPE)
		7.5. Aluminum
		7.6. Paper & Paper Board
	8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
		8.1. Tablets
		8.2. Capsules
		8.3. Powders
		8.4. Medical Devices
	9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
		9.1. North America
		9.2. Latin America
		9.3. Western Europe
		9.4. Eastern Europe
		9.5. South Asia and Pacific
		9.6. East Asia
		9.7. Middle East and Africa
	10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
	17. Key Countries Market Analysis
	18. Market Structure Analysis
	19. Competition Analysis
		19.1. ACG Pharmapack Pvt. Ltd
		19.2. Amcor Limited
		19.3. Bemis Company Inc
		19.4. Bilcare Research Inc
		19.5. Constantia Flexibles GmbH
		19.6. Display Pack, Inc
		19.7. Honeywell International Inc
		19.8. Klöckner Pentaplast Group
		19.9. Rohrer Corporation
		19.10. Sonoco Products Company
	20. Assumptions & Acronyms Used
	21. Research Methodology
Recommendations

Packaging

Medicine Blister Market

November 2023

REP-GB-18288

306 pages

Packaging

Bio-medical Packaging Market

August 2023

REP-GB-4565

315 pages

Explore Packaging Insights

View Reports
Future Market Insights

Medicine Blister Market

Schedule a Call